Synphilin-1 is present in lewy bodies in Parkinson's disease

Annals of Neurology

Volumn 47, Issue 4, 2000, Pages 521-523

  Wakabayashi, Koichi ^a   Engelender, Simone ^c,d   Yoshimoto, Makoto ^b   Tsuji, Shoji ^a   Ross, Christopher A ^c   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN TISSUE; LEWY BODY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CARRIER PROTEINS; HUMANS; LEWY BODIES; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; RABBITS; SUBSTANTIA NIGRA; SYNUCLEINS;

EID: 0034085796     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B     Document Type: Article

References (20)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
2. Krüger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998;8:106-108
3. Dunnett SB, Björklund A. Prospects for new restorative and neuroproteccive treatments in Parkinson's disease. Nature 1999; 399:A32-A39
4. Hardy J, Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science 1998;282:1075-1079
5. Spillantini MG, Schmidt ML, Lee VM, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-840
6. Takeda A, Mallory M, Sundsmo M, et al. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 1998;152:367-372
7. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-884
8. Wakabayashi K, Hayashi S, Kakita A, et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 1998;96:445-452
9. Jellinger K. Overview of morphological changes in Parkinson's disease. Adv Neurol 1986;45:1-18
10. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-191
11. Goldman JE, Yen SH, Chiu FC, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983;221:1082-1084
12. Maroteaux L, Scheller RH. The rat brain synucleins: family of proteins transiently associated with neuronal membrane. Mol Brain Res 1991;11:335-343
13. Jensen PH, Nielsen MS, Jakes R, et al. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998;273:26292-26294
14. Engelender S, Kaminsky Z, Guo X, et al. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 1999;22:110-114
15. Glued and other cytoskeletal related proteins. Hum Mol Genet 1997; 13:2205-2212
16. Wakabayashi K, Hayashi S, Yoshimoto M, et al. NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 2000;99:14-20
17. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998;4A:1318-1320
18. El-Agnaf OM, Jakes R, Curran MD, Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. FEBS Lett 1998;440:67-70
19. Narhi L, Wood SJ, Steavenson S, et al. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J Biol Chem 1999;274:9843-9846
20. Farrer M, Gwinn-Hardy K, Hutton M, Hardy J. The genetics of disorders with synuclein pathology and parkinsonism. Hum Mol Genet 1999;8:1901-1905